Farshad Forouzandeh (@farshadforouz) 's Twitter Profile
Farshad Forouzandeh

@farshadforouz

MD, PhD, FACC, FSCAI. Associate Prof.@cwru-Interventional Cardiologist @UHhospitals-#Emory Alumni- UH Parma Cath Lab Director-Patient Advocate

ID: 842868723048464388

linkhttps://scholar.google.com/citations?user=m-5Bx0cAAAAJ&hl=en&oi=ao calendar_today17-03-2017 22:42:18

887 Tweet

1,1K Followers

531 Following

JACC Journals (@jaccjournals) 's Twitter Profile Photo

In 1987, Dr. Nanette Wenger was the lead author of the original Bethesda Conference on CVD in the Elderly, which anticipated the impact of an aging population on #CVD burden. She & her team now return, 4 decades later, w/ an update on where we are & where we need to be heading:

In 1987, Dr. <a href="/NanetteWenger/">Nanette Wenger</a> was the lead author of the original Bethesda Conference on CVD in the Elderly, which anticipated the impact of an aging population on #CVD burden. She &amp; her team now return, 4 decades later, w/ an update on where we are &amp; where we need to be heading:
SCAI (@scai) 's Twitter Profile Photo

#LateBreaking science from #CRT2024! Read key #InterventionalCardiology takeaways from 5 trials featured at this year’s meeting with top takeaways drafted by SCAI experts ➡️ bit.ly/CRT24Takeaways CRT Meeting Farshad Forouzandeh Chadi Alraies, MD FACC FSCAI Tim Simpson Brian Kolski,MD Allison Dupont, MD

#LateBreaking science from #CRT2024! Read key #InterventionalCardiology takeaways from 5 trials featured at this year’s meeting with top takeaways drafted by SCAI experts ➡️ bit.ly/CRT24Takeaways
<a href="/CRT_meeting/">CRT Meeting</a> <a href="/FarshadForouz/">Farshad Forouzandeh</a> <a href="/chadialraies/">Chadi Alraies, MD FACC FSCAI</a> <a href="/TimSimpsonMD/">Tim Simpson</a> <a href="/bkolskk/">Brian Kolski,MD</a> <a href="/Allison_Dupont/">Allison Dupont, MD</a>
Farshad Forouzandeh (@farshadforouz) 's Twitter Profile Photo

Do you remember when you joined X? I do! #MyXAnniversary Thankful to X to provide a reliable platform for connecting with friends, colleagues, and beyond and a great learning media under the leadership of Elon Musk & Linda Yaccarino

Do you remember when you joined X? I do! #MyXAnniversary Thankful to X to provide a reliable platform for connecting with friends, colleagues, and beyond and a great learning media under the leadership of <a href="/elonmusk/">Elon Musk</a> &amp; <a href="/lindayaX/">Linda Yaccarino</a>
Farshad Forouzandeh (@farshadforouz) 's Twitter Profile Photo

When all 3 opening late breaking RCTs have neutral primary endpoints, i.e. null hypothesis cannot be rejected, it means few things: -better and more rigorous RCTs are being done, -it is hard to add incremental value to already available therapies, -there is data transparency

When all 3 opening late breaking RCTs have neutral primary endpoints, i.e. null hypothesis cannot be rejected, it means few things: -better and more rigorous RCTs are being done, -it is hard to add incremental value to already available therapies, -there is data transparency
Farshad Forouzandeh (@farshadforouz) 's Twitter Profile Photo

Awesome complication cases #coronary track CV Innovations 2024 in Denver sho casing difficult cases with complications and how to troubleshoot them. A very interactive =TED style talks and conversations👍Perfect venue to learn from the masters Emmanouil Brilakis @maf204 Dr. Seto

Awesome complication cases #coronary track <a href="/cvinnovations/">CV Innovations</a> 2024 in Denver sho casing difficult cases with complications and how to troubleshoot them. A very interactive =TED style talks and conversations👍Perfect venue to learn from the masters <a href="/esbrilakis/">Emmanouil Brilakis</a> @maf204 <a href="/arnoldseto/">Dr. Seto</a>